Symbol
| NCAPG2
| contributors: mct - updated : 29-01-2019
|
HGNC name
| non-SMC condensin II complex, subunit G2
|
HGNC id
| 21904
|
corresponding disease(s)
|
MRSRBD
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in non-small cell lung cancer tissues compared to adjacent normal lung tissues, and significantly correlated with lymph node metastasis and pathologic-Tumour Nodes Metastasen stages | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| poor prognostic biomarker in lung adenocarcinoma | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | | | |
simultaneous targeting of NCAPG2 and TRAPPC2 is a promising strategy for the development of antitumor drugs as a treatment for intractable tumours |
| | |
| suppression and mutation of Ncapg2 results in apoptosis and altered mitotic progression in Zebrafish Larvae |